Passive immunization against tumour necrosis factor‐alpha (TNF‐α) and IL‐lβ protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats

Glomerular injury caused by injection of heterologous anti‐glomerular basement membrane antibodies (anti‐GBM Ab) is increased in rats pretreated with small doses of bacterial lipopolysaccharide (LPS). We have investigated the involvement of tumour necrosis factor‐alpha (TNF‐α), IL‐lα and IL‐1 β in this phenomenon by passive immunization against these cytokines. Anti‐TNF‐α or anti‐IL‐1β antibodies given 1–5 h before the induction of nephritis significantly decreased injury in this model, whether assessed by the magnitude of albuminuria, the prevalence of glomerular capillary thrombi or the intensity of glomerular neutrophil infiltrate. Albuminuria in anti‐GBM Ab alone was 11 ± 3, LPS/anti‐GBM Ab 87±22, and anti‐TNF‐α antibodies/LPS/anti‐GBM Ab 21 ±6 mg/24 h (mean ± s.e.) P< 0.05. Passive immunization with antibodies to IL‐1 β had a similar effect (anti‐GBM Ab, 0.6±01, LPS/anti‐GBM Ab, 92±19, anti‐IL‐1β antibodies/LPS/anti‐GBM Ab 39 ± 8 mg/24 h, P<0.05). The prevalence of glomerular capillary thrombi was also reduced significantly by these treatments; from 22 ± 5% to 4± 1% in the case of anti‐TNF‐α antibodies and 28±5% to 13±4% with anti‐IL‐1β antibodies. Similarly, the glomerular neutrophil infiltrate was also reduced by these treatments; from 42±3 to 25±1 in the case of anti‐TNF‐α and 47± 2 to 30± 1 with anti‐IL‐1α antibodies. In contrast, passive immunization against IL‐1α had no effect on either albumin excretion (4±3, 83±22 and 77±24 mg/24 h), glomerular capillary thrombi (2±1; 19±5 and 16±3) or glomerular neutrophil infiltrate (22± 3; 47± 5 and 48± 5 from the three groups respectively). These results demonstrate that enhanced antibody mediated injury in the kidney is modulated by TNF‐α and IL‐14bT but not by IL‐lα.

[1]  S. J. Cashman,et al.  Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin‐1 , 1991, British journal of pharmacology.

[2]  A. Vander,et al.  Roles of interleukin 1 beta and tumor necrosis factor in lipopolysaccharide fever in rats. , 1990, The American journal of physiology.

[3]  W. Fiers,et al.  Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. , 1990, Cancer research.

[4]  O. Ramilo,et al.  Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation , 1990, The Journal of experimental medicine.

[5]  O. Söder,et al.  Interleukin-1β, but not interleukin-1α, induces acute inflammation-like changes in the testicular microcirculation of adult rats , 1990 .

[6]  P. Bossù,et al.  Differential activity of interleukin 1α and interleukin 1β in the stimulation of the immune response in vivo , 1990 .

[7]  K. Tracey,et al.  Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia , 1989, The Journal of experimental medicine.

[8]  A. Rees,et al.  Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. , 1989, Journal of immunology.

[9]  D. Fry,et al.  Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. , 1989, Archives of surgery.

[10]  R. Cotran,et al.  Effects of cytokines on vascular endothelium: their role in vascular and immune injury. , 1989, Kidney international.

[11]  C. Dinarello,et al.  Interleukin-1 induces natriuresis in conscious rats: role of renal prostaglandins. , 1988, Kidney international.

[12]  T. Hirano,et al.  Action of recombinant human interleukin 6, interleukin 1β and tumor necrosis factor α on the mRNA induction of acute‐phase proteins , 1988 .

[13]  T. Ikejima,et al.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. , 1988, The Journal of clinical investigation.

[14]  A. Issekutz,et al.  Synergy Between Tumour Necrosis Factorα and Interleukin‐1 in the Induction of Polymorphonuclear Leukocyte Migration During Inflammation , 1988, Journal of leukocyte biology.

[15]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[16]  M. Cybulsky,et al.  Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury. , 1987, The American journal of pathology.

[17]  T. Ulich,et al.  Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. , 1987, Journal of immunology.

[18]  P. Vassalli,et al.  Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease , 1987, The Journal of experimental medicine.

[19]  L. F. Fajardo,et al.  Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. , 1987, Science.

[20]  A. Arimura,et al.  Stimulation of ACTH release by human interleukin-1β, but not by interleukin-1α, in conscious, freely-moving rats , 1987 .

[21]  J. Gauldie,et al.  Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte-stimulating factors and monokines in rat hepatoma cells. , 1987, The Journal of biological chemistry.

[22]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[23]  B. Beutler,et al.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 , 1986, The Journal of experimental medicine.

[24]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[25]  L. Ruilope,et al.  Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy. , 1985, Kidney international.

[26]  J. Playfair,et al.  Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. , 1984, Clinical and experimental immunology.

[27]  A. Rees,et al.  Relapses in Wegener's granulomatosis: the role of infection. , 1980, British medical journal.

[28]  H. Movat,et al.  Kinetics of acute inflammation induced by E coli in rabbits. Quantitation of blood flow, enhanced vascular permeability, hemorrhage, and leukocyte accumulation. , 1980, The American journal of pathology.

[29]  T. Miller,et al.  The rapid isolation of ribonuclease-free immunoglobulin G by protein A-sepharose affinity chromatography. , 1978, Journal of immunological methods.

[30]  A. Rees,et al.  Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection. , 1977, British medical journal.

[31]  F. Gauthier,et al.  Rat alpha2 acute-phase macroglobulin. Isolation and physicochemical properties. , 1976, The Biochemical journal.

[32]  D. Wilson,et al.  Mesangiocapillary glomerulonephritis with dense "deposits" in the basement membranes of the kidney. , 1976, Clinical nephrology.

[33]  W. Heim Relation between Rat Slow Alpha2-globulin and Alpha2-macroglobulin of Other Mammals , 1968, Nature.

[34]  L. Ayvazian,et al.  Disseminated lupus erythematosus occurring among student nurses. , 1948, The New England journal of medicine.

[35]  G. Duff,et al.  Interleukin 1: the first interleukin. , 1990, Immunology today.

[36]  C. Dinarello Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.

[37]  M. Cybulsky,et al.  Acute inflammation in gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils. , 1987, Federation proceedings.

[38]  R. Lechler,et al.  Progression to renal failure after nephrotoxic nephritis in rats studied by renal transplantation. , 1985, Clinical science.